Want to see HK:1609 full AI Analyst Report?

Star Sports Medicine Co., Ltd Class H (1609) Ratios

― Followers

Star Sports Medicine Co., Ltd Class H Ratios

See a summary of HK:1609’s cash flow.

Ratios	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	5.04	4.11	5.74	5.56
Quick Ratio	―	4.55	3.66	5.19	5.08
Cash Ratio	―	0.89	0.71	5.05	4.90
Solvency Ratio	―	0.98	0.75	0.91	2.54
Operating Cash Flow Ratio	―	1.20	0.74	1.13	1.00
Short-Term Operating Cash Flow Coverage	―	13.09	0.00	0.00	0.00
Net Current Asset Value	¥ ―	¥ 504.96M	¥ 376.27M	¥ 328.63M	¥ 290.99M
Leverage Ratios
Debt-to-Assets Ratio	―	0.04	0.04	0.02	0.03
Debt-to-Equity Ratio	―	0.05	0.05	0.02	0.03
Debt-to-Capital Ratio	―	0.05	0.05	0.02	0.03
Long-Term Debt-to-Capital Ratio	―	0.03	0.03	0.00	0.00
Financial Leverage Ratio	―	1.25	1.31	1.20	1.06
Debt Service Coverage Ratio	―	12.33	311.60	145.00	86.89
Interest Coverage Ratio	―	476.65	290.73	122.95	63.16
Debt to Market Cap	―	<0.01	<0.01	0.00	0.00
Interest Debt Per Share	―	0.60	0.42	0.16	0.21
Net Debt to EBITDA	―	-0.50	-0.55	-4.48	-5.42
Profitability Margins
Gross Profit Margin	―	74.14%	69.58%	74.33%	70.90%
EBIT Margin	―	38.36%	32.99%	27.17%	28.09%
EBITDA Margin	―	42.05%	37.25%	32.56%	32.97%
Operating Profit Margin	―	40.59%	31.28%	25.05%	23.83%
Pretax Profit Margin	―	38.28%	32.88%	26.96%	27.71%
Net Profit Margin	―	34.01%	29.16%	23.94%	27.52%
Continuous Operations Profit Margin	―	34.01%	29.16%	23.94%	27.52%
Net Income Per EBT	―	88.84%	88.68%	88.79%	99.31%
EBT Per EBIT	―	94.30%	105.11%	107.65%	116.31%
Return on Assets (ROA)	―	17.93%	15.45%	12.66%	11.63%
Return on Equity (ROE)	―	22.48%	20.24%	15.24%	12.29%
Return on Capital Employed (ROCE)	―	25.82%	20.88%	15.69%	11.99%
Return on Invested Capital (ROIC)	―	22.44%	18.38%	13.82%	11.79%
Return on Tangible Assets	―	17.95%	15.56%	12.78%	11.70%
Earnings Yield	―	2.82%	1.88%	1.17%	0.85%
Efficiency Ratios
Receivables Turnover	―	9.64	16.65	80.05	42.31
Payables Turnover	―	3.75	4.23	4.75	7.20
Inventory Turnover	―	1.62	1.74	1.56	1.58
Fixed Asset Turnover	―	4.57	3.67	5.90	4.94
Asset Turnover	―	0.53	0.53	0.53	0.42
Working Capital Turnover Ratio	―	0.87	0.90	0.81	0.57
Cash Conversion Cycle	―	166.56	145.16	161.85	189.51
Days of Sales Outstanding	―	37.88	21.92	4.56	8.63
Days of Inventory Outstanding	―	226.00	209.61	234.18	231.59
Days of Payables Outstanding	―	97.32	86.37	76.89	50.70
Operating Cycle	―	263.88	231.53	238.74	240.21
Cash Flow Ratios
Operating Cash Flow Per Share	―	2.87	1.72	1.46	1.02
Free Cash Flow Per Share	―	2.24	1.23	1.07	0.86
CapEx Per Share	―	0.62	0.50	0.39	0.16
Free Cash Flow to Operating Cash Flow	―	0.78	0.71	0.73	0.85
Dividend Paid and CapEx Coverage Ratio	―	4.59	3.48	3.76	6.55
Capital Expenditure Coverage Ratio	―	4.59	3.48	3.76	6.55
Operating Cash Flow Coverage Ratio	―	4.82	4.19	9.59	5.05
Operating Cash Flow to Sales Ratio	―	0.39	0.29	0.33	0.38
Free Cash Flow Yield	―	2.53%	1.33%	1.20%	0.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	35.39	53.17	85.82	117.53
Price-to-Sales (P/S) Ratio	―	12.04	15.51	20.52	32.53
Price-to-Book (P/B) Ratio	―	7.96	10.76	13.06	14.53
Price-to-Free Cash Flow (P/FCF) Ratio	―	39.48	75.31	83.51	100.83
Price-to-Operating Cash Flow Ratio	―	30.88	53.67	61.28	85.45
Price-to-Earnings Growth (PEG) Ratio	―	0.81	0.79	2.12	0.00
Enterprise Value Multiple	―	28.15	41.07	58.52	93.26
Enterprise Value	―	4.77B	5.01B	4.55B	4.51B
EV to EBITDA	―	28.15	41.07	58.52	93.26
EV to Sales	―	11.84	15.30	19.06	30.75
EV to Free Cash Flow	―	38.79	74.31	77.57	95.30
EV to Operating Cash Flow	―	30.34	52.96	56.92	80.76
Tangible Book Value Per Share	―	11.09	8.52	6.75	5.95
Shareholders’ Equity Per Share	―	11.11	8.59	6.83	5.99
Tax and Other Ratios
Effective Tax Rate	―	0.11	0.11	0.11	<0.01
Revenue Per Share	―	7.35	5.97	4.35	2.67
Net Income Per Share	―	2.50	1.74	1.04	0.74
Tax Burden	―	0.89	0.89	0.89	0.99
Interest Burden	―	1.00	1.00	0.99	0.99
Research & Development to Revenue	―	0.12	0.11	0.15	0.12
SG&A to Revenue	―	0.12	0.13	0.21	0.17
Stock-Based Compensation to Revenue	―	<0.01	<0.01	<0.01	0.00
Income Quality	―	1.02	0.88	1.24	1.37

Currency in CNY